Beximco Pharmaceuticals Ltd. GDR Stock
Heavy losses for Beximco Pharmaceuticals Ltd. GDR today as the stock fell by -€0.035 (-6.360%).
Pros and Cons of Beximco Pharmaceuticals Ltd. GDR in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Beximco Pharmaceuticals Ltd. GDR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Beximco Pharmaceuticals Ltd. GDR | -6.360% | 0.000% | 7.292% | 18.119% | 14.955% | 4.675% | -46.632% |
| Eledon Pharmaceuticals Inc. | -1.490% | 8.152% | 9.341% | -50.000% | 55.469% | -7.870% | -85.038% |
| SELLAS Life Sciences Group Inc | -0.600% | 18.750% | 14.364% | 279.310% | 47.443% | 154.103% | -38.202% |
| Grifols S.A. ADR | 0.000% | -4.459% | -1.961% | 7.143% | -1.316% | -10.180% | -40.608% |
News
Why Atai Life Sciences Stock Was So Lively This Week
Atai Life Sciences (NASDAQ: ATAI), a biotech focused on developing psychedelic-based medicines to treat mental health disorders, was a standout stock over the past few days in its rather limited
Why Atai Life Sciences Stock Crushed It on Tuesday
Atai Life Sciences (NASDAQ: ATAI), an ambitious biotech that targets mental health disorders, was a hot item among equity investors Tuesday. The company saw its share price rise by just under 15%